原发性肝癌肝外转移癌六例再切除体会

Re-resection of extrahepatic metastatic primary liver carcinoma

目的探讨原发性肝癌肝外转移癌再切除的应用和价值。方法回顾性分析1986年至2008年我院27例原发性肝癌再切除中的6例肝外转移癌的临床治疗资料,其中肺部转移癌2例,腹腔转移癌4例。结果6例肝外转移癌切除均无手术死亡及术后并发症发生,术后中位生存期从再次切除算起4.6年。结论原发性肝癌肝外转移癌的高选择性再切除是安全有效的,可明显延长生存期。腹腔、肺部癌结节选择再切除或伽玛刀治疗,腹腔种植癌和浸润癌灶行切除术,可明显延长生存期,是进一步提高疗效的重要途径。

Objective To evaluate the prospective outcome and summarize experience in re - resection of extrahepatic metastatic primary liver carcinoma. Methods The data of 6 patients with extrahepatic metastatic primary liver carcinoma who had undergone tumor re-resection from 1986 to 2008 were retrospectively analyzed. Results The 6 patients after the re-resection did not show any complications. Their median survival time was 4.6 years. Conclusions High selective re-resection of extrahepatic metastatic tumor is safe and effective. Either selective excision or gamma knife is capable of treating peritoneal cavity metastasis or lung metastasis. Seeding neoplasm or invasive neoplasm in the peritoneal cavity may be treated by resection. The re-resection of tumors with extrahepatic metastases provides the possibility of longer survival, also it is an important way to enhance the efficacy of the treatment.